Transendocardial delivery of AAV6 results in highly efficient and global cardiac gene transfer in rhesus macaques

Human Gene Therapy

Volumn 22, Issue 8, 2011, Pages 979-984

  Gao, Guangping ^a   Bish, Lawrence T ^b   Sleeper, Meg M ^c   Mu, Xin ^a   Sun, Lan ^d   Lou, You ^d   Duan, Jiachuan ^e   Hu, Chunyan ^e   Wang, Li ^e   Sweeney, H Lee ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Clinical Studies   (United States)

^d SICHUAN UNIVERSITY   (China)

^e National Chengdu Center for Safety Evaluation of Drugs   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE; RHESUS MONKEY; SEROTYPE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MACACA MULATTA; MALE; MYOCARDIUM; RANDOM ALLOCATION;

ADENO-ASSOCIATED VIRUS 6; ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 80052016960     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.042     Document Type: Article

References (30)

1. Beeri, R., Chaput, M., Guerrero, J.L., et al. (2010). Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circ. Heart Fail. 3, 627-634.
2. Bell, P., Gao, G., Haskins, M.E., et al. (2011). Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs. Hum. Gene Ther. doi:10.1089/hum.2010.194. [Epub ahead of print]
3. Bish, L.T., Sleeper, M.M., Brainard, B., et al. (2008). Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. Mol. Ther. 16, 1953-1959.
4. Bish, L.T., Sleeper, M.M., and Sweeney, H.L. (2011). Percutaneous transendocardial delivery of self-complementary adeno-asso-ciated virus 6 in the canine. Methods Mol. Biol. 709, 369-378.
5. Chaanine, A.H., Kalman, J., and Hajjar, R.J. (2010). Cardiac gene therapy. Semin. Thorac. Cardiovasc. Surg. 22, 127-139.
6. Gao, G., Wang, Q., Calcedo, R., et al. (2009). Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses. Hum. Gene Ther. 20, 930-942.
7. Herzog, R.W., Yang, E.Y., Couto, L.B., et al. (1999). Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5, 56-63. (Pubitemid 29050999)
8. Jaski, B.E., Jessup, M.L., Mancini, D.M., et al. (2009). Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J. Card. Fail. 15, 171-181.
9. Katz, M.G., Swain, J.D., Low, D., et al. (2010). Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum. Gene Ther. 21, 371-380.
10. Kawase, Y., Ladage, D., and Hajjar, R.J. (2011). Method of gene delivery in large animal models of cardiovascular diseases. Methods Mol. Biol. 709, 355-367.
11. Mariani, J.A., and Kaye, D.M. (2010). Delivery of gene and cellular therapies for heart disease. J. Cardiovasc. Transl. Res. 3, 417-426.
12. Mariani, J.A., Smolic, A., Preovolos, A., et al. (2011). Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure. Eur. J. Heart Fail. 13, 247-253.
13. Marshall, D.J., Palasis, M., Lepore, J.J., and Leiden, J.M. (2000). Biocompatibility of cardiovascular gene delivery catheters with adenovirus vectors: an important determinant of the efficiency of cardiovascular gene transfer. Mol. Ther. 1, 423-429.
14. McCarty, D.M., Monahan, P.E., and Samulski, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254. (Pubitemid 32780813)
15. McTiernan, C.F., Mathier, M.A., Zhu, X., et al. (2007). Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts. Gene Ther. 14, 1613-1622. (Pubitemid 350143187)
16. Muller, O.J., Leuchs, B., Pleger, S.T., et al. (2006). Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc. Res. 70, 70-78.
17. Njeim, M.T., and Hajjar, R.J. (2010). Gene therapy for heart failure. Arch. Cardiovasc. Dis. 103, 477-485.
18. Pacak, C.A., Mah, C.S., Thattaliyath, B.D., et al. (2006). Re-combinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3-e9. (Pubitemid 44255502)
19. Pepe, M., Mamdani, M., Zentilin, L., et al. (2010). In-tramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy. Circ. Res. 106, 1893-1903.
20. Raake, P.W., Hinkel, R., Muller, S., et al. (2008). Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther. 15, 12-17. (Pubitemid 350284205)
21. Roncalli, J., Tongers, J., and Losordo, D.W. (2010). Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure. Arch. Cardiovasc. Dis. 103, 469-476.
22. Sasano, T., Kikuchi, K., McDonald, A.D., et al. (2007). Targeted high-efficiency, homogeneous myocardial gene transfer. J. Mol. Cell. Cardiol. 42, 954-961. (Pubitemid 46678029)
23. Sipo, I., Fechner, H., Pinkert, S., et al. (2007). Differential inter-nalization and nuclear uncoating of self-complementary ade-no-associated virus pseudotype vectors as determinants of cardiac cell transduction. Gene Ther. 14, 1319-1329. (Pubitemid 47370845)
24. Su, H., Huang, Y., Takagawa, J., et al. (2006). AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Gene Ther. 13, 1495-1502. (Pubitemid 44567147)
25. Swain, J.D., Katz, M.G., White, J.D., et al. (2011). A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal. Methods Mol. Biol. 709, 331-354.
26. Tao, Z., Chen, B., Tan, X., et al. (2011). Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc. Natl. Acad. Sci. U.S.A. 108, 2064-2069.
27. Tarantal, A.F., and Lee, C.C. (2010). Long-term luciferase expression monitored by bioluminescence imaging after adeno-associated virus-mediated fetal gene delivery in rhesus monkeys (Macaca mulatta). Hum. Gene Ther. 21, 143-148.
28. Tarantal, A.F., McDonald, R.J., Jimenez, D.F., et al. (2005). In-trapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery. Mol. Ther. 12, 87-98. (Pubitemid 40862360)
29. White, J.D., Thesier, D.M., Swain, J.B., et al. (2011). Myocardial gene delivery using molecular cardiac surgery with recombi-nant adeno-associated virus vectors in vivo. Gene Ther. doi: 10.1038/gt.2010.168. [Epub ahead of print]
30. Xie, J., Xie, Q., Zhang, H., et al. (2011). MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression. Mol. Ther. 19, 526-535.